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Abstract
Background: This study aims to analyze the computed tomography (CT) and magnetic resonance imaging(MRI)
characteristics of hepatic epithelioid hemangioendothelioma (HEHE).
Methods: Eleven patients with histopathologically confirmed HEHE via surgical excision or biopsy were included.
Imaging findings of these 11 patients were retrospectively analyzed (CT images obtained from all patients and MR
images from five patients). Patterns of growth, characteristics of distribution, density/signal features, patterns of
contrast enhancement, and changes of adjacent tissues were evaluated.
Results: HEHE is characterized by multiple lesions in the liver. HEHE could be further categorized as three types
when considering patterns of growth: nodular type(5 cases), coalescent type(1 case) and mixed type(5 cases). In this
study, a total of 312 lesions were detected, 214(74.3 %) of which were subcapsular. All lesions appeared as hypodense
while round lower density were found within 10 lesions(<2 cm) on unenhanced CT images. On MRI, all lesions
demonstrated low signal intensity on T1 weighted images and high heterogeneous signal intensity on T2 weighted
images when compared to the normal liver parenchyma. Other imaging features included “lollipop sign”(6 cases) and
capsular retraction(6 cases). On contrast-enhanced CT and MRI, lesions smaller than 2.0 cm mostly showed mild
homogeneous enhancement (214/227, 94.3 %); lesions measuring 2.0–3.0 cm in diameter showed ring-like
enhancement (16/53,30.2 %) and heterogeneous delayed enhancement (29/53,54.7 %); lesions larger than 3.0 cm
demonstrated heterogeneous delayed enhancement (26/32, 81.3 %).
Conclusion: The imaging findings of HEHE showed some typical imaging features and size-dependent patterns
with contrast enhancement on both CT and MR images, these features can be used for accurate imaging
diagnosis of HEHE.
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Background
Epithelioid hemangioendothelioma (EHE) is a rare, low-
grade malignant vascular tumor [1–3]. It was first de-
scribed as a distinct entity by Weiss and Enzinger in
1982 [4]. EHE occurs mostly in soft tissues of the ex-
tremities and various visceral organs (lung, bone, brain and
intestine, etc.). Primary hepatic epithelioid hemangioen-
dothelioma (HEHE) is a very rare type of malignant tumor
first reported by Ishak et al in 1984 [5]. Clinical manifesta-
tions of hepatic epithelioid hemangioendothelioma (HEHE)
are nonspecific, such as right upper quadrant pain, hepato-
megaly and weight loss while many patients remain asymp-
tomatic at diagnosis [2]. The duration of clinical symptoms
ranges from 3 months to 2 years before the diagnosis of
HEHE is made [3]. Laboratory examination shows that
liver enzymes can be moderately elevated, but tumor
marker levels (alpha-fetoprotein, carcinoembryonic antigen
and cancer antigen 19-9) are usually normal. Therefore,
clinical diagnosis of HEHE remains very difficult where
imaging investigations, especially computed tomog-
raphy (CT) or magnetic resonance imaging (MRI), play
an important role in the diagnosis of HEHE.
To our best knowledge, current imaging studies on
HEHE remained very limited, most of which, if any, were
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about sporadic cases and small case series. In this study,
we retrospectively analyzed the CT and MRI features of
histopathologically confirmed HEHE in 11 patients. We
emphatically described imaging findings of HEHE, in-
cluding the patterns of growth and patterns of contrast




The study was conducted in accordance with ethical
guidelines for human research and was compliant with
the Health Insurance Portability and Accountability Act
(HIPAA). As such, the study received IRB or ethical
committee approval, and that written informed consent
was obtained from all patients. The ethics approval was
provided by The First Affiliated Hospital, Sun Yat-Sen
University, China.
Eleven patients with HEHE, histopathologically con-
firmed by surgical excision or biopsy, were recruited at our
centre from 2003 to 2013. Histopathologically, tumor cells
of HEHE consist of epithelial and dendritic cells. Tumor
cells grow along pre-existing sinusoids with intervening
collagenous fibrosis. They typically exhibit intracytoplas-
mic lumina, containing erythrocytes. Immunohistochemis-
try stains are positive for Vimentin and CD34 [1].
Among these 11 cases, there were six males and five fe-
males, with ages ranging from 25 to 57 years old (mean,
37.8 years old).
CT protocol
All patients underwent contrast-enhanced CT examina-
tions (Aquilion 64, Toshiba). The contrast medium
injected was iopromide (Ultravist, 300mgI/ml) with a
dose of 1.5 ml/kg and a injection rate of 3.5–4.0 ml/s.
Images were obtained separately at the arterial phase
(34–37 s after injection), portal venous phase (60–70s
after injection) and delayed phase (3 min–5 min after in-
jection). The scanning parameters included: tube voltage,
120 kV; tube current, 250 mA; pitch, 0.9; matrix, 512 ×
512; slice thickness, 0.5 mm.
MR imaging
All MR examinations were performed on a 3.0 T scanner
(Magnetom Trio, Siemens Healthcare Sector) with an
eight-channel torso-array coil. All patients underwent
breathing training to ensure imaging quality and were
examined in supine position after a fasting period of 4 h.
The scanning range covered from the dome of the dia-
phragm to the last plane of the liver. Unenhanced scan-
ning included axial T1-weighted images (acquired matrix,
256 × 192; TR, 200 ms; TE, 2.2 ms) and axial T2-weighted
images (acquired matrix, 256 × 192; TR, 6000 ms; TE,
80 ms). Dynamic contrast-enhanced scan was performed
with a 3D-VIBE sequence (volume interpolated breath
hold examination) with the following parameters: acquired
matrix, 256 × 192; TR, 3.3 ms; TE, 1.1 ms; section thick-
ness, 2 mm; intersection gap, 1 mm. The contrast medium
was applied in terms of a bolus injection of Gd-DTPA
with a dose of 2 mmol/ (kg body weight) and an injection
rate of 2 ml/s. Dynamic images were obtained 15 s after
injection. The other parameters of MRI scanning were:
field of view, 380 × 380 mm; flip angle, 12°; time obtained,
16 s.
Image analysis
All CT and MR images were reviewed independently by
two experienced radiologists who were blinded to the
identity of patients and their clinical outcome. They ana-
lyzed the images in terms of patterns of growth, charac-
teristics of distribution, size, characteristics of density
(sign) and patterns of contrast enhancement respect-
ively. The recorded results were based on consensus.
Comparison among the three groups of contrast en-
hancement were made using Kruskal-Wallis H test. The
three pairwise comparisons were tested and Bonferroni’s
adjustment was applied, the reported P values are two-
sided and reflect Bonferroni’s adjustment. All statistical
calculations were performed using SPSS software (ver-
sion 17.0). Two-sided P values of less than 0.05 were
considered to indicate statistical significance.
Results
Multiple lesions were found in the liver. According to
the patterns of growth, these 11 cases can be divided
into three types: nodular type, the lesions were circular
or nodular (5/11, 45.5 %) (Fig. 1); coalescent type, the
multiple lesions were peripheral subcapsular distribution
with partial coalescence (1/11, 9.0 %) (Fig. 2); and mixed
type, the lesions with both types mentioned above (5/11,
45.5 %) (Fig. 3). A total of 312 lesions were detected, and
214 (74.3 %) of them were subcapsular. Lesions were more
frequently found in the right lobe (197/312, 63.1 %). The
tumors ranged from 0.3 cm to 20 cm in size with 227/312
(72.8 %) lesions smaller than 2.0 cm, 53/312(17.0 %) be-
tween 2.0 cm and 3.0 cm, and 32/312(10.2 %) larger than
3.0 cm.
All lesions were hypodense in appearance and round
lower density were found within 10 lesions (<2 cm) on
unenhanced CT scanning without calcifications. Five pa-
tients with MR examination had 61 lesions in MRI. All
lesions demonstrated low signal intensity on T1
weighted images and high heterogeneous signal intensity
on T2 weighted images compared to the normal liver
parenchyma (Fig. 4).
In summary, the lesions showed three patterns of en-
hancement on both contrast-enhanced CT and MR im-
ages. The first pattern is mild homogeneous enhancement:
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Fig. 1 Axial unenhanced CT (a) showed that multiple nodular lesions (indicated by white and black arrow) were homogeneous and hypodense
in the liver. Capsular retraction also could be seen (indicated by black arrow). Axial arterial phase (b) showed the lesion (indicated by the white
arrows) was ring-like enhancement. Axial portal vein phase (c) showed the lesion (indicated by white arrow) was progressive enhancement. Axial
delayed phase (d) the lesion (indicated by white arrow) was progressive enhancement
Fig. 2 Axial unenhanced CT scan (a) showed lesions were homogeneous, lamellar, hypodense and subcapsular. Axial arterial phase (b) showed the
lesions were heterogeneous enhancement, and a blood vessel tapered toward the lesions and was ended in the lesions (indicated by white arrow). Axial
portal vein phase (c) showed the lesions were progressive enhancement. Coronal contrast-enhanced CT scan (d) showed the lesions were subcapsular
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mild homogeneous enhancements during the arterial
phase, but no evidence of progressive enhancements
during portal vein phase or delayed phase (223/312,
71.5 %) (Fig. 3). The second pattern is ring-like en-
hancement: peripheral enhancement in the arterial
phase and progressive enhancement during portal vein
phase and delayed phase (Fig. 1). The third pattern is
heterogeneous delayed enhancement: heterogeneous
enhancement during arterial phase and progressive en-
hancement during portal vein phase and delayed phase
(Fig. 2). Lesions smaller than 2.0 cm mostly demon-
strated mild homogeneous enhancement (214/227,
94.3 %); lesions measuring 2.0–3.0 cm showed ring-like
enhancement (16/53, 30.2 %) and heterogeneous de-
layed enhancement (29/53, 54.7 %); and the lesions lar-
ger than 3 cm demonstrated heterogeneous delayed
enhancement (26/32, 81.3 %). Retraction of the liver
capsule overlying tumors was detected in six patients
(6/11, 54.5 %) (Fig. 1). Six patients showed “lollipop
sign” (6/11, 54.5 %), that is, the hepatic vein, portal vein
and their branches are tapering toward the lesions and
terminating at the edge of the tumor, which forms the
appearance of a lollipop (Fig. 2). Capsular retraction
and “lollipop sign” were found in lesions larger than
2.0 cm. No metastases or ascites were found in this
cohort.
The imaging findings of all 11 cases are shown in
Table 1. The relationship between the lesion size and the
patterns of contrast enhancement is shown in Fig. 5.
Comparison among the three patterns of contrast en-
hancement by using Kruskal-Wallis H test reported an
H of 226 with P < 0.001 and two-sided P values were
shown in Table 2.
Pathology findings
Neoplastic cells in all 11 cases demonstrated presence of
epithelial and dendritic cells with pleomorphic and
polyhedral appearance; CD34 was positive in all patients
(Fig. 6).
Discussion
HEHE is a rare, low-grade malignant vascular tumor.
The risk factors are currently unknown. It may be re-
lated to the use of oral contraceptive pills, chronic
hepatitis B, excessive drinking and past history of chlor-
oethylene exposure [1, 6]. The tumor is usually found
in adults and shows a slight female predominance
(male-to-female ratio, 2:3). The peak age of diagnosis is
30–40 years old [1, 3, 7]. HEHE can be divided into
solitary lesion and multiple lesions in the liver. It has
been reported that most of HEHE cases are character-
ized by multiple lesions, solitary lesion only accounts
for 13 % – 18 % [1, 2]. All patients in the study were
characterized by multiple lesions in the liver. Metasta-
ses have been reported in 27 %–37 % of patients, usu-
ally in the lung, and other common sites including
regional lymph nodes, peritoneum, omentum, mesen-
tery and bone. However, no metastases or ascites were
found in the study.
Pathologically, HEHE tumor cells in our study demon-
strated presence of intracytoplasmic lumina and erythro-
cytes with positive CD34 which were consistent with the
findings obtained from previous reports,
Lesions of HEHE are more frequently subcapsular
[8, 9], and 74.3 % of the lesions were subcapsular in
our study. According to previous reports, there are
two patterns of growth in the gross appearance of
HEHE: the nodular type and the diffuse type [10].
However, three types were identified in our study,
including nodular type, coalescent type and mixed
type, in HEHE, in which the coalescent type has
seldom been reported in previous reports. Nodular
type (45.5 %) and mixed type (45.5 %) accounted for
Fig. 3 Axial unenhanced CT scan (a) showed lesion (indicated by the white arrow) was homogeneous, hypodense and subcapsular. Axial arterial
phase (b) showed the lesion (indicated by the white arrow) was mild homogeneous enhancement. Axial portal vein phase (c) showed the lesion
(indicated by the white arrow) was not progressive enhancement
Zhou et al. BMC Gastroenterology  (2015) 15:69 Page 4 of 8
the vast majority of HEHE in the study. The simple co-
alescent type presented in only one case, however there
were six cases (54.5 %) with coalescent growth. We
consider that mild mass effect of coalescent type is a
characteristic manifestation of HEHE. In other tumors
the pattern of coalescent growth was rarely found,
hence this pattern may be an important implication to
the diagnosis of HEHE.
Fig. 4 Axial unenhanced MRI scan showed lesions (indicated by the white arrow) were low signal intensity on T1WI (a) and high heterogeneous
signal intensity on T2WI (b). The lesions (indicated by the white arrow) showed heterogeneous enhancement in the arterial phase (c), progressive
enhancement in portal vein phase and in delayed phase (d and e). Axial CT images (indicated by the white arrow) were similar to MRI images
(f, g and h)
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All lesions were hypodense on unenhanced CT. Calci-
fication is considered as one of the common features
seen in approximately 15 %–25 % of patients as sug-
gested by previous reports, however, our findings
showed inconsistent data. This may be due to the rela-
tively small sample size (11) in our study. All lesions
observed demonstrated low signal intensity on T1
weighted images and high heterogeneous signal inten-
sity on T2 weighted images compared to the normal
liver parenchyma.
Miller et al [11] reported capsular retraction as an im-
portant finding of HEHE. The pathological basis is hep-
atic fibrosis caused by the lesion and compensatory
hypertrophy of unaffected hepatic segments [12–14]. In
our study, six cases showed capsular retraction in lesions
larger than 2.0 cm. This may be explained by that larger
tumors are more likely to be located in the hepatic sub-
capsule or to cause local hepatic fibrosis. However,
capsular retraction may also be one of the features seen
in other benign or malignant liver lesions, such as chol-
angiocarcinoma and metastatic carcinoma. Therefore,
capsular retraction remains an important finding but not
a specific sign of HEHE.
Another important finding of HEHE is the “lollipop
sign” as reported by Alomari et al in 2006 [15], who
thought that “lollipop sign” was a characteristic finding
of HEHE. Six cases showed “lollipop sign” in the study.
“Lollipop sign” rarely occurs in most benign and malig-
nant hepatic tumors, hence it can be considered as more
characteristic finding of HEHE.
Dynamic contrast-enhanced scanning plays an import-
ant role in the diagnosis of HEHE. In general, as a vascu-
lar tumor, HEHE shows delayed enhancement in
dynamic enhanced scanning. In this study, we found that
the lesions showed three patterns of contrast enhance-
ment, including mild homogeneous enhancement, ring-
Table 1 The imaging features of all cases with hepatic epithelioid hemangioendothelioma













1 nodular type 9 - - √ - √
2 nodular type 35 √ - √ √ √
3 mixed type 11 - √ √ - √
4 nodular type 16 √ - √ √ -
5 mixed type 24 √ √ - √ √
6 nodular type 105 - - √ - √
7 mixed type 7 √ - √ - √
8 nodular type 19 - √ √ - √
9 coalescent type 1 √ √ - - √
10 mixed type 76 - √ √ √ √
11 mixed type 9 √ √ √ - √
Fig. 5 The relationship between the size of lesion and patterns of contrast enhancement
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like enhancement and heterogeneous delayed enhance-
ment. We also found that the patterns of contrast en-
hancement were closely related to the size of lesions.
Smaller lesions (<2.0 cm) mostly showed mild homoge-
neous enhancement. With the enlargement of the lesions,
HEHE could be characterized by multiple enhanced pat-
terns. Lager lesions (>3.0 cm) mostly showed heteroge-
neous delayed enhancement. We consider that different
patterns of contrast enhancement are related to patho-
logical basis. Pathologically, the tumor tissues include epi-
thelial and dendritic cells in variable proportions [1, 3, 16].
Larger tumor cells typically demonstrate presence of intra-
cytoplasmic lumina containing erythrocytes, which resem-
bles signet ring-like structures [17]. The peripheral tumor
cells grow along preexisting sinusoids and terminal hep-
atic venules. Atrophic hepatocytes are obliterated. These
may lead to heterogeneous enhancement of HEHE [1].
The presence of peripheral rich cellular zone and tissue
edema may contribute to high density during enhanced
scanning. The presence of abundant mucinous and
stroma may contribute to the lack of central unen-
hanced areas [10, 18].
Based on our findings, HEHE could be discriminated
from its differential diagnosis such as hepatic meta-
static carcinoma, cholangiocarcinoma, and other liver
vascular tumors like hepatic angiosarcoma or cavern-
ous hemangioma.
The image features of hepatic metastatic carcinoma
are more complicated. Similar to HEHE, this disease
shows ring-like enhancement or nonspecific enhancement.
However, the following tips could be applied in distinguish-
ing hepatic metastatic carcinoma from HEHE: a known
history of a primary malignancy; most commonly seen as
peripheral enhancement lesions together with less com-
mon features such as delayed enhancement and invading
blood vessels. Further more, HEHE lesions mostly demon-
strate mild to moderate FDG uptake, while hepatic meta-
static carcinoma commonly demonstrate intense FDG
uptake. PET-CT could be used to detect the presence of
metastatic tumor affecting distant organs to provide ac-
curate staging.
For cholangiocarcinoma, it usually grows along the
bile ducts. The adjacent bile ducts are nearly always
dilated or are embedded by tumors. Invaded blood
vessels are also shown. Cancer antigen 19-9 is usually
elevated.
Other hepatic vascular tumors can be discriminated
from HEHE, Hepatic cavernous hemangioma usually
demonstrate more regular and obvious enhancement with
similar appearances to arteries during arterial phase. On
the other hand, hepatic angiosarcoma, a high-grade malig-
nant vascular tumor, is often characterized by its irregu-
lar enhancement during arterial phase with enhanced
nodular edge during portal vein phase or in delayed
phase. Capsular retraction are usually not seen in hep-
atic vascular tumors.
Conclusion
In conclusion, HEHE is rare, but it demonstrates several
characteristics on imaging such as the presence of co-
alescent growth and “lollipop sign” to allow differenti-
ation from other hepatic tumors. When interpreting
these images, it should be kept in mind that the pattern
of contrast enhancement are related to the size of le-
sions. Therefore, the pattern of enhancement can be
variable on both MRI and CT, it can be used as a reliable
indicator for the diagnosis of HEHE.
Table 2 Two-sided P values
Groups Mann-Whitney U Z P
Mild and Ring-like 1086.50 −13.141 <0.001
Mild and heterogeneous 168.00 −13.369 <0.001
Ring-like and heterogeneous 611.00 −2.546 0.022
Fig. 6 Micrograph (×200; hematoxylin-eosin stain) (a) showed some tumor cells presented intracellular vascular lumina with cytoplasmatic vacuoles
containing erythrocytes. Immunohistochemistry (×200; CD 34 antibody stain) (b) showed positive results for CD34
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